119 related articles for article (PubMed ID: 3229065)
21. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
22. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
23. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
25. The importance of parametrial lymph nodes in the treatment of cervical cancer.
Girardi F; Lichtenegger W; Tamussino K; Haas J
Gynecol Oncol; 1989 Aug; 34(2):206-11. PubMed ID: 2753426
[TBL] [Abstract][Full Text] [Related]
26. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of lymph node status and lymph node morphology in cervix cancer operated by the Wertheim-Meigs-Okabayashi method].
Geppert M; Smyczek-Gargya B; Dekorsy A; König PA
Zentralbl Gynakol; 1992; 114(3):122-6. PubMed ID: 1595306
[TBL] [Abstract][Full Text] [Related]
28. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
31. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB
Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
33. Parametrial involvement in women with low-risk, early-stage cervical cancer.
Vanichtantikul A; Tantbirojn P; Manchana T
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
35. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
[TBL] [Abstract][Full Text] [Related]
36. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis.
Matsuyama T; Inoue I; Tsukamoto N; Kashimura M; Kamura T; Saito T; Uchino H
Cancer; 1984 Dec; 54(12):3072-7. PubMed ID: 6498784
[TBL] [Abstract][Full Text] [Related]
37. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer.
Zreik TG; Chambers JT; Chambers SK
Obstet Gynecol; 1996 May; 87(5 Pt 1):741-6. PubMed ID: 8677078
[TBL] [Abstract][Full Text] [Related]
38. [Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence].
Hellebrekers BW; Zwinderman AH; Kenter GG; Peters AA; Fleuren GJ; Trimbos JB
Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2304-9. PubMed ID: 11143298
[TBL] [Abstract][Full Text] [Related]
39. [Laterally extended parametrectomy in cases with cervical carcinoma].
Slavchev B; Markov P; Slavov S
Akush Ginekol (Sofiia); 2011; 50(5):24-30. PubMed ID: 22482157
[TBL] [Abstract][Full Text] [Related]
40. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.
Gemer O; Eitan R; Gdalevich M; Mamanov A; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Ben Shachar I; Ben Arie A; Lavie O
Eur J Surg Oncol; 2013 Jan; 39(1):76-80. PubMed ID: 23131429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
